Sievert, K.-D.; Hansen, T.; Titze, B.; Schulz, B.; Omran, A.; Brockkötter, L.; Gunnemann, A.; Titze, U.
Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics 2022, 12, 1146.
https://doi.org/10.3390/diagnostics12051146
AMA Style
Sievert K-D, Hansen T, Titze B, Schulz B, Omran A, Brockkötter L, Gunnemann A, Titze U.
Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics. 2022; 12(5):1146.
https://doi.org/10.3390/diagnostics12051146
Chicago/Turabian Style
Sievert, Karl-Dietrich, Torsten Hansen, Barbara Titze, Birte Schulz, Ahmad Omran, Lukas Brockkötter, Alfons Gunnemann, and Ulf Titze.
2022. "Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics" Diagnostics 12, no. 5: 1146.
https://doi.org/10.3390/diagnostics12051146
APA Style
Sievert, K.-D., Hansen, T., Titze, B., Schulz, B., Omran, A., Brockkötter, L., Gunnemann, A., & Titze, U.
(2022). Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics. Diagnostics, 12(5), 1146.
https://doi.org/10.3390/diagnostics12051146
